Comorbidity Five Years After Gastric Bypass
Comorbidity Five Years After Gastric Bypass
To evaluate effect on comorbid disease and weight loss five years after Roux-en-Y gastric
 bypass (RYGB) surgery for morbid obesity.
Morbid obese patient frequently have comorbid diseases, e.g. diabetes, hypertension,
 hyperlipidemia, and sleep apnea. We will study the remission rate and weight loss five years
 after Roux-en-Y gastric bypass (RYGB) surgery in a nationwide large group of patients.
Inclusion Criteria:

 -  Registered individuals in Scandinavian Obesity Surgery Registry (SOReg) having had
 gastric bypass

 Exclusion Criteria:

 -  All other operations